Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

USP47 inhibitor

DRUG CLASS:

USP47 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

TRIP13 mutation + MYC mutation	Multiple Myeloma	TRIP13 mutation + MYC mutation	Multiple Myeloma	P5091 Sensitive: D – Preclinical P5091 Sensitive : D	P5091 Sensitive: D – Preclinical P5091 Sensitive : D
EZH2 mutation	Diffuse Large B Cell Lymphoma	EZH2 mutation	Diffuse Large B Cell Lymphoma	USP47 inhibitor Sensitive: D – Preclinical USP47 inhibitor Sensitive : D	USP47 inhibitor Sensitive: D – Preclinical USP47 inhibitor Sensitive : D
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	P22077 Sensitive: D – Preclinical P22077 Sensitive : D	P22077 Sensitive: D – Preclinical P22077 Sensitive : D